Providing expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia.
Welcome to Lucid Health Consulting
With over 30 years of Health Economics, Pricing & Reimbursement, Strategic Market Access and Health Technology Assessment experience, we have helped many organisations navigate the complexities of the Australian regulatory environment and achieve market access.
We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.
Let us show you how our strategic approach and team experience can help you achieve market access in Australia.
How we can help your business?
Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.
The HTAi Annual Meeting for 2023 was held this year in Adelaide on 24 – 28 June, with the theme: "The Road to Policy and Clinical Integration" The road to policy and clinical integration for health technologies is filled with diverse and complex challenges to...
Registration is now open for the ISPOR 2023 Conference, May 7 – 10 in Boston, MA, USA. This conference is the leading international conference for health economics and outcomes research (HEOR) and is a must-attend event providing dedicated opportunities to network...
The ISPOR Europe 2022 Global Conference for Health Economics and Outcomes Research (HEOR) was held this year on 6-9 November, in-person in Vienna and virtually for discussion and dissemination of the latest trends in healthcare. This year’s conference theme was:...
What our clients are saying.
The Lucid Health Consulting team did a fantastic job with our funding application. The indication was complex, with multiple sub-populations and a varied treatment pathway. But they put together a clear and well-reasoned clinical evaluation, and translated this into a compelling economic assessment. Their broad experience and expertise meant they could provide valuable strategic insights throughout the submission process, ultimately leading to a positive recommendation the first time of asking – no mean feat. I would highly recommend their services.
Market Access Manager, Takeda.
The Lucid team’s thoughtful consideration of the strategic direction of a submission, their expert economic modelling skills and their ability to draw out the narrative of the value proposition ensures that the overall cost-effectiveness outcome is compelling to technical evaluators and general payers alike.
Head of Patient Services & Government Affairs ANZ, Baxalta
Lucid Heath Consulting are excellent to work with. All of their work is both scientifically rigorous and clearly articulated. Our very complex case was presented to us in a compelling way. The Directors at Lucid Health Consulting, have a great hands on approach and good direct dialogue with the relevant people in our organisation. We enjoyed working with Lucid Health Consulting and would recommend them and use them ourselves for our future projects.
Executive Director Integrated Market Access, Janssen-Cilag
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.